Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections Deresinski SClin Infect Dis 2009[Oct]; 49 (7): 1072-9Vancomycin is often combined with a second antibiotic, most often rifampin or gentamicin, for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Published data from experiments evaluating these and other vancomycin-based combinations, both in vitro and in animal models of infection, often yield inconsistent results, however. More importantly, no data are available from randomized clinical trials to support their use, and some regimens are known to have potential toxicities. Clinicians should carefully reconsider the use of vancomycin-based combination therapies for the treatment of infection due to methicillin-resistant S. aureus.|Animals[MESH]|Anti-Bacterial Agents/adverse effects/*therapeutic use[MESH]|Disease Models, Animal[MESH]|Drug Therapy, Combination[MESH]|Gentamicins/adverse effects/therapeutic use[MESH]|Humans[MESH]|Methicillin-Resistant Staphylococcus aureus/*drug effects/isolation & purification[MESH]|Randomized Controlled Trials as Topic[MESH]|Rifampin/adverse effects/therapeutic use[MESH]|Staphylococcal Infections/*drug therapy/*microbiology[MESH]|Treatment Outcome[MESH]|Vancomycin/adverse effects/*therapeutic use[MESH] |